Combining network pharmacology and experimental verification to reveal the mechanism of Chaigui granules in the treatment of depression through PI3K/Akt/mTOR signaling pathways.
Jun-Sheng TianZhen-Ning WuDan WuChen YangYao GaoDong-Lan YanXue-Mei QinPublished in: Metabolic brain disease (2023)
Based on the results of network pharmacology and animal experiment validation, Chaigui granules may reverse CUMS-induced depression-like behavior in rats through PI3K/Akt/mTOR signaling pathway.